These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 23604079)
21. Bak activation for apoptosis involves oligomerization of dimers via their alpha6 helices. Dewson G; Kratina T; Czabotar P; Day CL; Adams JM; Kluck RM Mol Cell; 2009 Nov; 36(4):696-703. PubMed ID: 19941828 [TBL] [Abstract][Full Text] [Related]
22. Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design. Brouwer JM; Lan P; Cowan AD; Bernardini JP; Birkinshaw RW; van Delft MF; Sleebs BE; Robin AY; Wardak A; Tan IK; Reljic B; Lee EF; Fairlie WD; Call MJ; Smith BJ; Dewson G; Lessene G; Colman PM; Czabotar PE Mol Cell; 2017 Nov; 68(4):659-672.e9. PubMed ID: 29149594 [TBL] [Abstract][Full Text] [Related]
23. Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. Oh KJ; Singh P; Lee K; Foss K; Lee S; Park M; Lee S; Aluvila S; Park M; Singh P; Kim RS; Symersky J; Walters DE J Biol Chem; 2010 Sep; 285(37):28924-37. PubMed ID: 20605789 [TBL] [Abstract][Full Text] [Related]
24. BCL-2 selectively interacts with the BID-induced open conformer of BAK, inhibiting BAK auto-oligomerization. Ruffolo SC; Shore GC J Biol Chem; 2003 Jul; 278(27):25039-45. PubMed ID: 12721291 [TBL] [Abstract][Full Text] [Related]
25. Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells. Miyake K; Bekisz J; Zhao T; Clark CR; Zoon KC Biochim Biophys Acta; 2012 Aug; 1823(8):1378-88. PubMed ID: 22683989 [TBL] [Abstract][Full Text] [Related]
26. Characterization of an alternative BAK-binding site for BH3 peptides. Ye K; Meng WX; Sun H; Wu B; Chen M; Pang YP; Gao J; Wang H; Wang J; Kaufmann SH; Dai H Nat Commun; 2020 Jul; 11(1):3301. PubMed ID: 32620849 [TBL] [Abstract][Full Text] [Related]
27. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Willis SN; Fletcher JI; Kaufmann T; van Delft MF; Chen L; Czabotar PE; Ierino H; Lee EF; Fairlie WD; Bouillet P; Strasser A; Kluck RM; Adams JM; Huang DC Science; 2007 Feb; 315(5813):856-9. PubMed ID: 17289999 [TBL] [Abstract][Full Text] [Related]
28. The BCL-2 family member BID plays a role during embryonic development in addition to its BH3-only protein function by acting in parallel to BAX, BAK and BOK. Ke FS; Holloway S; Uren RT; Wong AW; Little MH; Kluck RM; Voss AK; Strasser A EMBO J; 2022 Aug; 41(15):e110300. PubMed ID: 35758142 [TBL] [Abstract][Full Text] [Related]
29. An interconnected hierarchical model of cell death regulation by the BCL-2 family. Chen HC; Kanai M; Inoue-Yamauchi A; Tu HC; Huang Y; Ren D; Kim H; Takeda S; Reyna DE; Chan PM; Ganesan YT; Liao CP; Gavathiotis E; Hsieh JJ; Cheng EH Nat Cell Biol; 2015 Oct; 17(10):1270-81. PubMed ID: 26344567 [TBL] [Abstract][Full Text] [Related]
30. Examining BCL-2 family function with large unilamellar vesicles. Asciolla JJ; Renault TT; Chipuk JE J Vis Exp; 2012 Oct; (68):. PubMed ID: 23070252 [TBL] [Abstract][Full Text] [Related]
31. Methods to Probe Conformational Activation and Mitochondrial Activity of Proapoptotic BAK. Singh G; Moldoveanu T Methods Mol Biol; 2019; 1877():185-200. PubMed ID: 30536007 [TBL] [Abstract][Full Text] [Related]
32. BH3-only activator proteins Bid and Bim are dispensable for Bak/Bax-dependent thrombocyte apoptosis induced by Bcl-xL deficiency: molecular requisites for the mitochondrial pathway to apoptosis in platelets. Kodama T; Takehara T; Hikita H; Shimizu S; Shigekawa M; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Yin XM; Hayashi N J Biol Chem; 2011 Apr; 286(16):13905-13. PubMed ID: 21367852 [TBL] [Abstract][Full Text] [Related]
33. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. Zhang J; Huang K; O'Neill KL; Pang X; Luo X Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874 [TBL] [Abstract][Full Text] [Related]
34. Structural insights into proapoptotic signaling mediated by MTCH2, VDAC2, TOM40 and TOM22. Veresov VG; Davidovskii AI Cell Signal; 2014 Feb; 26(2):370-82. PubMed ID: 24269536 [TBL] [Abstract][Full Text] [Related]
35. The X-ray structure of a BAK homodimer reveals an inhibitory zinc binding site. Moldoveanu T; Liu Q; Tocilj A; Watson M; Shore G; Gehring K Mol Cell; 2006 Dec; 24(5):677-688. PubMed ID: 17157251 [TBL] [Abstract][Full Text] [Related]
37. Structure of the BAK-activating antibody 7D10 bound to BAK reveals an unexpected role for the α1-α2 loop in BAK activation. Robin AY; Miller MS; Iyer S; Shi MX; Wardak AZ; Lio D; Smith NA; Smith BJ; Birkinshaw RW; Czabotar PE; Kluck RM; Colman PM Cell Death Differ; 2022 Sep; 29(9):1757-1768. PubMed ID: 35279694 [TBL] [Abstract][Full Text] [Related]
38. Bid binding to negatively charged phospholipids may not be required for its pro-apoptotic activity in vivo. Manara A; Lindsay J; Marchioretto M; Astegno A; Gilmore AP; Esposti MD; Crimi M Biochim Biophys Acta; 2009 Oct; 1791(10):997-1010. PubMed ID: 19463967 [TBL] [Abstract][Full Text] [Related]
39. Direct activation of full-length proapoptotic BAK. Leshchiner ES; Braun CR; Bird GH; Walensky LD Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E986-95. PubMed ID: 23404709 [TBL] [Abstract][Full Text] [Related]